Achieve Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACHV and other ETFs, options, and stocks.About ACHV
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor.
CEORichard Alistair Balfour Stewart
CEORichard Alistair Balfour Stewart
Employees25
Employees25
HeadquartersVancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded1991
Founded1991
Employees25
Employees25
ACHV Key Statistics
Market cap310.09M
Market cap310.09M
Price-Earnings ratio-4.23
Price-Earnings ratio-4.23
Dividend yield—
Dividend yield—
Average volume717.67K
Average volume717.67K
High today$6.03
High today$6.03
Low today$5.51
Low today$5.51
Open price$5.62
Open price$5.62
Volume1.26M
Volume1.26M
52 Week high$6.03
52 Week high$6.03
52 Week low$1.84
52 Week low$1.84
Stock Snapshot
With a market cap of 310.09M, Achieve Life Sciences(ACHV) trades at $5.86. The stock has a price-to-earnings ratio of -4.23.
As of 2026-01-17, Achieve Life Sciences(ACHV) stock has fluctuated between $5.51 and $6.03. The current price stands at $5.86, placing the stock +6.4% above today's low and -2.7% off the high.
The Achieve Life Sciences(ACHV)'s current trading volume is 1.26M, compared to an average daily volume of 717.67K.
During the past year, Achieve Life Sciences(ACHV) stock moved between $1.84 at its lowest and $6.03 at its peak.
During the past year, Achieve Life Sciences(ACHV) stock moved between $1.84 at its lowest and $6.03 at its peak.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ACHV. This list is generated using Robinhood data, and it’s not a recommendation.